Schedule a Meeting
Get a SampleFebruary 2025
The global cell and tissue preservation market size is calculated at USD 5.20 billion in 2025 and is forecasted to reach around USD 13 billion by 2034, accelerating at a CAGR of 8.31% from 2025 to 2034. The North America cell and tissue preservation market size surpassed USD 1.92 billion in 2024 and is expanding at a CAGR of 10.75% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
The global cell and tissue preservation market size was valued at USD 4.68 billion in 2024 and it is expected to hit over USD 13.00 billion by 2034 with a remarkable CAGR of 8.31% from 2025 to 2034.
The U.S. cell and tissue preservation market size was estimated at USD 1.32 billion in 2024 and is predicted to be worth around USD 4.08 billion by 2034 at a CAGR of 11.95% from 2025 to 2034.
North America was the leading cell and tissue preservation market in 2024. The demand for the advanced healthcare technology is higher in North America. The presence of advanced healthcare infrastructure and higher government investments in the research and development in the healthcare technology has significantly driven the growth of the cell and tissue preservation market. The increased prevalence of chronic diseases among the population of US has attracted heavy investments in drug discovery and development of innovative therapeutics, which has driven the growth of the North America cell and tissue preservation market.
Asia Pacific is expected to be the most opportunistic market during the forecast period. The increasing investments in development of advanced healthcare and medical infrastructure and the presence of several top pharmaceutical companies and research organizations are significantly contributing towards the growth of the Asia Pacific cell and tissue preservation market.
The global cell and tissue preservation market is significantly driven by the rising preservation of stem cells. The rising investments towards the development of healthcare infrastructure, adoption of smart technologies, and medical innovations are expected to foster the market growth during the forecast period. The globe is witnessing an increasing prevalence of various chronic diseases such as cardiovascular diseases, range of malignancies, diabetes, neurological disorders, and many other diseases, which is significantly boosting the growth of the global cell and tissue preservation market. The improved access to the better healthcare facilities owing to the rising disposable income, presence of developed healthcare infrastructure, and rising healthcare expenditure has led to the development of innovative bio-preservation technologies and facilities.
The adoption of the cryopreservation helps to extend the shelf life of some of the cells. The recent outbreak of the COVID-19 pandemic in 2020 has forced the companies to focus on reducing the risks of cross contamination especially at the fertility clinics and centers. The increasing demand for the regenerative therapies across the globe is expected to fuel the growth of the cell and tissue preservation market. The regenerative therapies helps in the restoration of the cells and tissues caused due to the age related diseases, congenital abnormalities, and injuries. Furthermore, the growing demand for storing organs for transplantation is another major factor that is anticipated to have a significant impact on the market growth in the foreseeable future.
| Report Coverage | Details |
| Growth Rate from 2025 to 2034 | CAGR of 8.31% |
| Market Size in 2025 | USD 5.20 Billion |
| Market Size by 2034 | USD 13.00 Billion |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | By Type, By Application, By Product, By End User, and By Cell Provider |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Based on the type, the cell segment led the global cell and tissue preservation market in 2024 with revenue share of 53% with a CAGR of 11.7% from 2025 to 2034. The rising demand for the cell therapies and regenerative therapies among the patients is expected to drive the market growth. Furthermore, the increasing prevalence of various diseases and the rising investments in the technological advancements to enhance the storage systems of cells is propelling the growth of this segment.
Tissue Segment is expected to be the fastest-growing segment during the forecast period. This growth is attributed to the increasing penetration of the biobanks across the globe. Furthermore, the rising demand for the regenerative medicines is significantly fostering the growth of this segment. The rising incidences of age related diseases and severe injuries are propelling the demand for the tissue preservation across the globe. The rising geriatric population across the globe is expected to further spur the growth of this segment in the forthcoming years. According to the United Nations, the elderly population across the globe is expected to reach around 2 billion by the year 2050, which will positively contribute towards the growth of the tissues segment in the cell and tissue preservation market.
On the basis of application, the therapeutics was the dominating segment that constituted revenue of around 40% in 2024 with a CAGR of 11.8% during the forecast period. The increased demand for the cell and tissue preservation for the development of therapeutics to cure various chronic and non-communicable diseases has led to the dominance of this segment across the globe. The rapidly surging prevalence of lifestyle and age related diseases is expected to foster the growth of this segment and is expected to sustain its position in the global cell and tissue preservation market throughout the forecast period.
IVF treatment segment is anticipated to exhibit highest CAGR during the forecast period. This is attributed to the rising demand for the IVF treatments across the globe. Late marriages, rising participation of women in workforce, higher preference to career over marriage, and several other factors are resulting in the declining fertility rates and growing complexities in the pregnancies. These factors are propelling the demand for the IVF treatment, which in turn is expected to drive the growth of the IVF treatment segment in the cell and tissue preservation market.
Depending on the product, the global cell and tissue preservation market was dominated by the equipment segment in 2024. The surging demand for the biobanks across the globe owing to its higher utilization in tissue, stem cell, Plasma, and DNA research has fueled the growth of the equipment segment. The equipment segment was valued at US$ 2,026 million in 2023 and it is expected to hit US$ 6,805 million in 2033, growing at a CAGR of 11.7% from 2024 to 2033. The increased adoption of the freezing and storage systems for the preservation of cells and tissues has led to the dominance of this segment in the global market. Furthermore, the high costs associated with the acquisition of the advanced and innovative equipment helped in the higher revenue generation.
Software segment is anticipated to be the most opportunistic segment during the forecast period. This rising investments in the adoption of software technologies owing to the rising trend of digitization and automation. The increasing needs for controlling costs and effectively manage the operations and inventories have fueled the adoption of the software technologies in the biobanks.
Based on the end user, the biobanks segment led the global cell and tissue preservation market accounting for over 68% of the market share in 2024. The rising demand for the stem cell preservation among the researchers has significantly fueled the growth the biobanks segment. Moreover, the rising advancements in the technology and growing investments in the research activities for the purpose of drug discovery and development of various therapeutics is further expected to drive the market growth.
The biobanks is also anticipated to be the fastest-growing segment during the forecast period. The surging number of egg and sperm banks and the rising adoption of the assisted reproductive technology is fueling the growth of the biobanks segment.
By Type
By Application
By Product
By End User
By Cell Provider
By Geography
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
February 2025
January 2025
January 2025
January 2025